PibrentasvirPibrentasvir is an NS5A inhibitor antiviral agent. In the United States and Europe, it is approved for use with glecaprevir as the combination drug glecaprevir/pibrentasvir (trade name Mavyret in the US and Maviret in the EU) for the treatment of hepatitis C. Read from the Drugbox of the Wikipedia article Pibrentasvir, revision 1360537432.

Property

Value

Formula

C57H65F5N10O8, 1113.20 g/mol

Protein binding

99.9 %

Elimination half-life

13 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.